Pharmacological Monotherapy for Depressive Disorders: Current and Future—A Narrative Review
MedicinaObjective: To narratively review currently available antidepressants and future potential antidepressants as monotherapy for the treatment of depressive disorders.
Keming Gao +2 more
doaj +1 more source
Pharmacoeconomics of antidepressants in a tertiary care teaching hospital of rural India
, 2022 Tanveer Khan +2 more
openalex +2 more sources
Developing medication independence: The experience of UK teenagers
British Journal of Clinical Pharmacology, EarlyView.Aims There is a progression through childhood from being provided medications by caregivers to having to take responsibility for medications yourself, but little is known about when the transition of adolescents managing medicines begins. The aim of this study was to obtain a cross‐sectional sample of UK adolescents and when they become independent ...
Holly Hutchins +5 more
wiley +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim The quantitative effect of several inhibitory drugs on the development of adverse drug reactions (ADRs) is currently difficult to estimate. Our aim was to identify metabolic pathways, which, when inhibited, increase the risk for certain ADRs, and to use this system to consider comedication at individual level. Methods Data of a prospective
Judith Berres +8 more
wiley +1 more source
Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder [PDF]
, 2008 Anthony J. Cleare
openalex +1 more source
Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
PLoS ONE, 2014 ObjectivesInflammation is involved in the pathogenesis of depression. A few cross-sectional population-based studies have found that depression is associated with increased levels of inflammatory markers. Soluble urokinase plasminogen activation receptor
Eva Haastrup +5 more
doaj +1 more source
RETRACTED ARTICLE: Monoaminergic and Nitriergic Modulation for Antidepressant-like Activity of Naringin in Unstressed and Acute Immobilization-Induced Stressed Mice [PDF]
, 2012 Mahesh Kumar +4 more
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran +5 more
wiley +1 more source
Antidepressant Therapeutic Drug Monitoring by Minimally Invasive Techniques in Eating Disorders Patients: Preliminary Results from a Pilot Study with Focus on Vortioxetine [PDF]
, 2020 Fabio Panariello
openalex +1 more source